Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Adagio Medical Holdings (ADGM) Shares Outstanding (2023 - 2026)

Adagio Medical Holdings has reported Shares Outstanding over the past 4 years, most recently at $22.2 million for Q1 2026.

  • Quarterly Shares Outstanding rose 44.4% to $22.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $22.2 million through Mar 2026, up 44.4% year-over-year, with the annual reading at $22.2 million for FY2025, 46.14% up from the prior year.
  • Shares Outstanding was $22.2 million for Q1 2026 at Adagio Medical Holdings, roughly flat from $22.2 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $22.2 million in Q4 2025 and troughed at $760572.0 in Q3 2023.
  • The 4-year median for Shares Outstanding is $15.2 million (2024), against an average of $11.2 million.
  • The largest YoY upside for Shares Outstanding was 1871.82% in 2025 against a maximum downside of 5.82% in 2025.
  • A 4-year view of Shares Outstanding shows it stood at $779908.0 in 2023, then surged by 1848.72% to $15.2 million in 2024, then soared by 46.14% to $22.2 million in 2025, then changed by 0.0% to $22.2 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Shares Outstanding are $22.2 million (Q1 2026), $22.2 million (Q4 2025), and $15.4 million (Q3 2025).